Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Long-term follow-up of heart scans after left atrial appendage closure in atrial fibrillation

Reviews past records of heart scans in adults with atrial fibrillation after appendage closure.

Plain-language title generated from the registry record
Registry title: Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

Key facts

Where
Overland Park, United StatesSee the site

Where in United States

  • Kansas City Heart Rhythm InstituteOverland Park, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Kansas City Heart Rhythm Research Foundation
Trial code
NCT06075628
Record updated
28 August 2025
Original description
This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic attacks (TIAs) in association with left atrial appendage contrast flow (LAA-CF). It will be a multi-center, retrospective study. Approximately 100 subject charts will be reviewed.Read full original descriptionShow less

Long-Term Outcomes of Left Atrial Appendage Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic attacks (TIAs) in association with left atrial appendage contrast flow (LAA-CF). It will be a multi-center, retrospective study. Approximately 100 subject charts will be reviewed.

Inclusion: Subjects must be at least 18 years of age; Subjects underwent LAA closure with Watchman/Watchman FLX or Amplatzer Amulet at our institution from January 2019 till June 2022.

Exclusion: No definite exclusion criteria are defined for the study as all patients with Watchman-FLX or Amplatzer Amulet will be included in the study.

ClinicalTrials.gov NCT06075628